The Canadian Journal of Clinical Pharmacology

Current Volume

Volume 17 (2)

Archives

Volume 12 (3) Fall 2005

TABLE OF CONTENTS

Can J Clin Pharmacol Vol 12(3) Fall 2005: e218-e221; Oct. 24, 2005
The role of buspirone for the treatment of cerbellar ataxia in an older individual
Brief report
Read Abstract Download PDF
Can J Clin Pharmacol Vol 12(3) Fall 2005: e222-e228; Oct. 24, 2005
Can Canada sustain paediatric phase I trials? A national survey of cancer relapse in children
Original research
Read Abstract Download PDF
Can J Clin Pharmacol Vol 12(3) Fall 2005: e229-e239; Oct. 24, 2005
Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians
Original research
Read Abstract Download PDF
Can J Clin Pharmacol Vol 12(3) Fall 2005: e240-e245; Oct. 24, 2005
Cardiovascular collapse from low dose bupivacaine
Case report
Read Abstract Download PDF
Can J Clin Pharmacol Vol 12(3) Fall 2005:e251-e253; Oct. 24, 2005
Compliance assessment in drug trials: Has there been improvement in two decades?
Brief report
Read Abstract Download PDF
Can J Clin Pharmacol Vol 12(3) Fall 2005: e254-e263; Nov. 7, 2005
Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis
Original research
Read Abstract Download PDF
Can J Clin Pharmacol Vol 12(3) Fall 2005: e264-e268; Nov. 8, 2005
Toxic epidermal necrolysis and clarithromycin
Case report
Read Abstract Download PDF
Can J Clin Pharmacol Vol 12(3) Fall 2005: e269-e275; Dec. 1, 2005
Pharmaceutical expenditure compared across countries
ICPE 2004 Lecture
Read Abstract Download PDF

Regulatory Affairs

Can J Clin Pharmacol Vol 12(3) Fall 2005: e246-e250; Oct. 24, 2005
Clinical trial applications in Canada
Read Abstract Download PDF

Canadian Society of Pharmacology and Therapeutics